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dence occurring between the second and fourth days
after the operation.15 This rate is even higher for
patients undergoing valve replacement, either alone or
in combination with CABG. For most patients, postop-
erative atrial arrhythmias are a benign complication,
without significant morbidity. Nonetheless, there is
ample evidence that they are associated with adverse
outcomes, including patient discomfort or anxiety, the
need for extra medications or treatments, the possibili-
ty of thromboembolic complications, and both
increased hospital length of stay and hospital costs.16-18
There are few data regarding the post-hospital discharge
course of patients with this complication, but it is gen-
erally believed that the risk of this arrhythmia decreas-
es substantially within the first month after surgery. It is
important to remember that in an era of early hospital
discharge, often on the third or fourth postoperative day,
these arrhythmias may occur after discharge and
patients should be counseled appropriately.
The treatment of patients with postoperative atrial
arrhythmias has not been standardized despite many
years of clinical experience and investigation. Direct-
current cardioversion is highly effective for restoring
sinus rhythm in most patients, but this procedure is typ-
ically reserved for patients with hemodynamic instabil-
ity. In clinical practice, most patients are treated med-
ically for their arrhythmias. There are two goals of
pharmacologic therapy: (1) control of the heart rate and
(2) conversion to a sinus rhythm. Medications such as
diltiazem, β-blockers, or digoxin can be used effective-
ly to control the heart rate, and drugs such as sotalol,
amiodarone, ibutilide, procainamide, and quinidine,
among others, can be used to restore sinus rhythm. Each
of these agents may be most appropriate for certain
patient groups, and all require specific monitoring dur-
ing treatment (ie, Q-T interval, serum levels). Because
pharmacologic therapy and/or cardioversion are so
effective, nearly all patients can be discharged in sinus
rhythm. For patients in whom sinus rhythm cannot be
restored, adequate heart rate control and anticoagula-
tion with warfarin sodium (Coumadin) are appropriate.
The pathogenesis of postoperative atrial arrhythmias
is not completely understood. On the basis of experi-
mental models, an underlying electrophysiologic abnor-
mality is a necessary substrate for these arrhythmias.19
In this issue of the Journal, Mueller and colleagues1report on their experience with postoperative atrial
arrhythmias in a series of 183 patients who underwent
isolated single coronary artery bypass grafting (CABG)
with the left internal thoracic artery placed to the left
anterior descending coronary artery. The authors
observed that the prevalence of postoperative atrial
arrhythmias was similar, at approximately 18% to 22%,
for patients having conventional CABG and for those
having beating-heart operations. With the development
and growing acceptance of technologies that facilitate
less invasive approaches for CABG, several recent, but
conflicting, reports have been published on the frequen-
cy of this complication.2-12 In light of an appreciable
change in the current practice of CABG, and the con-
flicting information regarding postoperative atrial fibril-
lation, it would be useful to reflect on what is presently
known about this complication and the most appropri-
ate direction for our future efforts in this area.
Large-scale longitudinal studies have demonstrated
that atrial fibrillation is the most common arrhythmia in
the general population.13,14 The prevalence of this
arrhythmia increases with age, with a prevalence of less
than 1% at age 50 but more than 9% to 10% at age 80.13
Other risk factors in the general population include con-
gestive heart failure, valvular heart disease, hyperten-
sion, diabetes, and a history of myocardial infarction.
Given these predisposing factors, it is not surprising
that this arrhythmia is a common complication in the
adult population having cardiac surgery.
Atrial arrhythmias have been recognized as a com-
mon postoperative complication since the earliest days
of CABG. These arrhythmias include atrial fibrillation,
atrial flutter, and paroxysmal atrial tachycardia. Clinical
studies have reported a prevalence of 25% to 40%
among patients undergoing CABG, with a peak inci-
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A nonuniform dispersion of refractoriness in the atrial
tissue can set up local areas of functional block. These
can be established simply by the process of aging (ie,
progressive fibrosis of the atrial tissue) or long-stand-
ing volume overload, but may also be affected by
events inherent in conventional cardiac surgical proce-
dures (ie, ischemia during cardioplegic arrest, cannula-
tion technique) or by changes that might occur after
any type of surgical procedure (ie, alterations in auto-
nomic tone). Regardless of how the substrate is estab-
lished, an initiating premature atrial contraction is also
required to begin the arrhythmia. From a theoretical
standpoint, patients undergoing beating-heart CABG
would not be subject to some of these precipitating fac-
tors (ie, atrial ischemia, cannulation techniques) but
would still be subject to others (ie, alterations in auto-
nomic tone). Unfortunately, our limited knowledge of
the pathogenesis and underlying mechanisms of these
arrhythmias has precluded the development of specific
therapies to prevent their occurrence.
A variety of strategies have been proposed over the
years to reduce the frequency of postoperative atrial
arrhythmias. Although numerous studies of pharmaco-
logic agents have been reported, the results have often
been conflicting.20-24 The most compelling evidence
supports the use of β-blockers postoperatively to reduce
the frequency of these arrhythmias.20 Moreover, β-
blocker withdrawal should be avoided because this prac-
tice is associated with an increase in the frequency of
these arrhythmias. The use of other drugs is more con-
troversial. Used prophylactically, the administration of
digoxin or supplementation with magnesium does not
appear to be effective.21,22 Calcium channel blockers,
particularly verapamil, can be associated with adverse
hemodynamic effects and are not effective for this pur-
pose. The prophylactic use of type Ia agents (ie, pro-
cainamide, quinidine) in this setting has not been studied
extensively, and they are rarely used by surgeons. The
use of type Ic antiarrhythmic agents (ie, sotalol, amio-
darone) has shown promise for at least some patient sub-
groups in several recent small studies. Amiodarone,
administered for several days before the operation, or
sotalol, used in low doses postoperatively, both appear to
reduce the frequency of postoperative atrial arrhyth-
mias.23,24 Further studies are clearly needed in this area.
Nonpharmacologic strategies may also be useful for
preventing this complication. A variety of pacing
strategies have been proposed in the early postoperative
period to reduce the number of premature atrial con-
tractions, but these approaches have produced only
limited success in reducing the prevalence of postoper-
ative atrial arrhythmias.25 The maze procedure is very
effective for preventing these arrhythmias, but the addi-
tion of this procedure carries a finite risk of additional
morbidity and mortality and has been reserved for
highly selected patients with preoperative chronic atri-
al fibrillation. Newer approaches involving a more lim-
ited “maze-like” procedure, including targeted isola-
tion of anatomic substrates, such as the pulmonary
veins, may have some applicability in the future26 if
they can be made less invasive and easy to perform.
However, their development awaits a clearer mechanis-
tic understanding of the necessary substrate required
for the initiation of these arrhythmias.
In the year 2000, up to 20% of all CABG operations
were performed with a “less invasive” approach.
Several approaches that avoid the use of cardiopul-
monary bypass are currently available, including mini-
mally invasive direct coronary artery bypass (MID-
CAB) using a mini-thoracotomy incision, off-pump
coronary artery bypass (OPCAB) using a conventional
sternotomy incision, and endoscopic approaches. Each
of these operations can be accomplished with the aid of
a variety of stabilization devices, bypass conduits, and
anesthetic techniques. On the basis of the technical
details of these operations, this is obviously a hetero-
geneous group of patients. Not surprisingly, the litera-
ture is replete with conflicting information regarding
the incidence of postoperative atrial arrhythmias after
minimally invasive CABG. In a retrospective, nonran-
domized survey, Buffolo and colleagues2 reported sig-
nificantly fewer arrhythmias (atrial and ventricular)
among patients who underwent OPCAB. Chauhan and
colleagues3 reported a lower prevalence of postopera-
tive atrial arrhythmias in a small number of patients
who underwent MIDCAB procedures than among
those who underwent conventional CABG procedures.
Allen and colleagues4 reported no postoperative atrial
arrhythmias in a small group of patients who under-
went single-vessel redo CABG with the left internal
thoracic artery to the left anterior descending coronary
artery using a MIDCAB approach. Subramanian,
McCabe, and Geller5 reported that postoperative atrial
fibrillation developed in 8% of patients (14/185)
undergoing a MIDCAB operation.
There are an equal number of negative studies show-
ing no difference in the incidence of postoperative atri-
al arrhythmias. Cohn, Sirois, and Johnson6 reported a
small case-control study in which there was no differ-
ence in the frequency of postoperative atrial arrhyth-
mias for patients who underwent MIDCAB and those
who underwent conventional CABG. Other “negative”
studies were reported by Abreu,7 Saatvedt,9 Siebert,10
and their colleagues. Each of these studies involved
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small numbers of patients in the groups not having car-
diopulmonary bypass. The small, retrospective, non-
randomized study by Mueller and colleagues1 in this
issue of the Journal reports similar findings. In another
retrospective review, Tamis-Holland and colleagues11
reported a lower frequency of postoperative atrial
arrhythmias among patients undergoing MIDCAB pro-
cedures compared with those undergoing conventional
CABG, but they attributed this finding to underlying
differences in the two patient groups. Unfortunately,
most of these studies were nonrandomized, retrospec-
tive case reports. All of these studies can be criticized
for not comparing identical patient groups undergoing
conventional versus less invasive CABG.
The most compelling evidence for a lower frequency
of postoperative atrial arrhythmias comes from a recent
prospective, randomized trial of 200 patients reported
by Ascione and colleagues.12 In this study, the preva-
lence of postoperative atrial arrhythmias was 49% in
the conventional CABG group but only 14% in the
beating-heart group. However, a criticism of this study
was the high incidence of arrhythmias in the conven-
tional group and a nonuniform use of β-blockers. 
Although the study by Mueller and colleagues1 in
this issue of the Journal reports on a very small num-
ber of patients and lacks the statistical power to detect
a meaningful difference in the rates of postoperative
atrial arrhythmias between the patient groups, the
authors’ observations are important to help set the stage
for further investigation. It is a common progression in
our field that anecdotal accounts are often followed by
small and then larger retrospective studies. It is obvious
that the ideal study to settle the issue would be a
prospective trial of conventional CABG versus less
invasive CABG, in which the development of postoper-
ative atrial arrhythmias was an end point. Un-
fortunately, as many as 1000 patients per group would
be needed to have sufficient statistical power to identi-
fy a 25% difference in the rates of postoperative atrial
arrhythmias. This would be a monumental undertaking,
but only rigorous prospective clinical investigation will
resolve many of the outstanding issues related to the
occurrence of postoperative atrial arrhythmias.
Real progress in this area will not occur until target-
ed laboratory investigation better elucidates the under-
lying mechanisms of postoperative atrial arrhythmias.
After almost 50 years of open cardiac surgery, the pre-
vention of one of the most common postoperative com-
plications remains elusive. Postoperative atrial arrhyth-
mias remain a vexing clinical problem crying for
meticulous, carefully controlled laboratory and clinical
research. Ideally, cardiac surgeons will rise to this chal-
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lenge in the coming decade and finally develop an
effective therapy based on a firm mechanistic founda-
tion to prevent this common cause of patient morbidity
after cardiac surgery.
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